CBHC saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on December 13, 2024. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 11 instances where the indicator turned negative. In of the 11 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CBHC's P/B Ratio (0.000) is slightly lower than the industry average of (1.030). P/E Ratio (0.000) is within average values for comparable stocks, (18.662). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.366). Dividend Yield (0.058) settles around the average of (0.058) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (2.921).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 64, placing this stock better than average.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CBHC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Industry RegionalBanks
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MPLSX | 10.21 | N/A | N/A |
MassMutual Strat Emerg Mkts Adm | |||
IHOAX | 18.94 | N/A | N/A |
Hartford International Opportunities A | |||
JOEAX | 11.62 | N/A | N/A |
JOHCM Emerging Markets Opps Investor | |||
MCGCX | 18.23 | -0.51 | -2.72% |
BlackRock Advantage Global Investor C | |||
FCWGX | 63.63 | -1.80 | -2.75% |
American Funds Capital World Gr&Inc529F2 |
A.I.dvisor indicates that over the last year, CBHC has been loosely correlated with HTLF. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CBHC jumps, then HTLF could also see price increases.
Ticker / NAME | Correlation To CBHC | 1D Price Change % | ||
---|---|---|---|---|
CBHC | 100% | N/A | ||
HTLF - CBHC | 39% Loosely correlated | -5.90% | ||
FMBL - CBHC | 30% Poorly correlated | -0.00% | ||
FULT - CBHC | 25% Poorly correlated | -4.05% | ||
FIEB - CBHC | 22% Poorly correlated | N/A | ||
FKKFY - CBHC | 4% Poorly correlated | N/A | ||
More |